SESSION TITLE: Lung Cancer II
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: The current management algorithm for locally advanced or metastatic non-small cell lung cancer (NSCLC) incorporates testing for multiple genetic alterations, which in turn is used to guide treatment decisions. Emerging targeted agents include kinase inhibitors of epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), ROS1, BRAF, RET, MET, and the human epidermal receptor (HER2neu). Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is increasingly used for the diagnosis and staging of lung cancer. The purpose of this study is to examine the yield of EBUS-TBNA in the subclassification and genotyping of NSCLC.